ADXS

Advaxis Stock Price

0.5527
0.00 (0.0%)
0.5527
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Advaxis Inc ADXS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.5527 0.00 0.00 0.00 0.5527 07:01:38
Bid Price Ask Price Spread Spread % News
0.5514 0.57 0.0186 3.26% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.5527 USD

Advaxis Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 34.05M 61.61M 61.54M $ 20.88M $ - 0.02 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Advaxis News

Date Time Source News Article
6/26/202016:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)
6/11/202016:02Edgar (US Regulatory)Quarterly Report (10-q)
5/08/202016:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/08/202016:06Edgar (US Regulatory)Current Report Filing (8-k)
5/05/202016:06Edgar (US Regulatory)Current Report Filing (8-k)
5/05/202016:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/05/202016:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADXS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.52850.57750.52110.5509132614,0210.02424.58%
1 Month0.84690.880.52010.63247121,473,759-0.2942-34.74%
3 Months0.65630.880.52010.68328371,300,949-0.1036-15.79%
6 Months1.241.350.410.87531112,859,902-0.6873-55.43%
1 Year1.792.140.2020.66057354,512,930-1.24-69.12%
3 Years6.3910.800.1811.052,113,429-5.84-91.35%
5 Years18.8422.200.1813.091,614,685-18.29-97.07%

Advaxis Description

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.
Your Recent History
NASDAQ
ADXS
Advaxis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200708 11:31:32